The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome

Cell Death and Disease

Volumn 4, Issue 3, 2013, Pages

  McGuire, C ^a   Rahman, M ^b   Schwaninger, M ^b   Beyaert, R ^a   Van Loo, G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

A20 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN; PROTEIN P50; PROTEIN P52; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

BRAIN ISCHEMIA; LETTER; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; C57BL MOUSE; CEREBRAL ARTERY DISEASE; GENETICS; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CYSTEINE ENDOPEPTIDASES; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 84875891686     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.55     Document Type: Letter

References (8)

1. Ridder DA, Schwaninger M. Neuroscience 2009; 158: 995-1006.
2. Inta I et al. J Neurosci 2006; 26: 12896-12903.
3. Nurmi A et al. Stroke 2004; 35: 987-991.
4. Schneider A et al. Nat Med 1999; 5: 554-559.
5. Herrmann O et al. Nat Med 2005; 11: 1322-1329.
6. Blondeau N et al. J Neurosci 2001; 21: 4668-4677.
7. Ma A, Malynn BA. Nat Rev Immunol 2012; 12: 774-785.
8. Vereecke L et al. J Exp Med 2010; 207: 1513-1523.